Overlapping long peptides that encompass both class I and class II peptides have been shown to generate strong T cell responses in numerous studies and many groups have reported that anti-tumor immunity is highly dependent on the presence of CD4 T cells (37–39). This evidence concerns the gene CD4 and neoplasm.